Vincerx Pharma Inc

NASDAQ:VINC   2:47:02 PM EDT
10.87
+0.10 (+0.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Vincerx Pharma Inc Stock, NASDAQ:VINC

260 Sheridan Avenue, Suite 400, Palo Alto, California 94306
US
Phone: +1.650.800.6676
Number of Employees: 28

Description

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.